ADAMTS13-binding IgG are present in patients with thrombotic thrombocytopenic purpura.
about
Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpuraThe molecular biology of thrombotic microangiopathyADAMTS13 and microvascular thrombosisADAMTS13 phenotype in plasma from normal individuals and patients with thrombotic thrombocytopenic purpuraThrombotic thrombocytopenic purpura: a thrombotic disorder caused by ADAMTS13 deficiencyNovel recombinant glycosylphosphatidylinositol (GPI)-anchored ADAMTS13 and variants for assessment of anti-ADAMTS13 autoantibodies in patients with thrombotic thrombocytopenic purpura.Gain-of-function ADAMTS13 variants that are resistant to autoantibodies against ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.Concurrent thrombotic thrombocytopenic purpura and immune thrombocytopenic purpura in a patient with metastatic neuroendocrine tumour successfully treated with rituximab-CVP.Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura.Characterization of conformation-sensitive antibodies to ADAMTS13, the von Willebrand cleavage proteaseMeasurement of ADAMTS13.Structure-function and regulation of ADAMTS-13 protease.Pathogenesis and treatment of acquired idiopathic thrombotic thrombocytopenic purpuraDissecting the pathophysiology of immune thrombotic thrombocytopenic purpura: interplay between genes and environmental triggers.
P2860
Q24620546-250950DA-DCED-42E0-BC40-AE33FEA1E8E1Q24648686-F75AA173-3C3B-4B2F-9C30-DB101FA2C5F9Q33373608-1C960A95-08B3-461B-AD7A-F3A58B9C7767Q33373698-96391A24-61E1-4539-BF4C-D4F44D057580Q33376071-A84D39C4-349C-49FE-8BE7-A5F15C2CE780Q33397081-EC2259A2-48A4-405F-8D77-0CCCDB435C9DQ33399396-EABA41C5-FE06-4AAF-8C6D-933E0AB2A91BQ33402349-57B9172E-76E5-466B-B1D3-7A6010B9F2A7Q33411525-6DC5A840-1DBD-451A-A443-2C9DF7C992C9Q33490606-170707AC-8942-4EC0-B0C3-39532513F8CDQ36161436-00B246D1-99A8-4B31-B710-65060CCA23F6Q37019574-B20707CB-FB47-4D5A-99A3-4AEC24AF94AFQ42434776-7D908FC9-D52D-45E9-A6D9-AA0FC029534CQ52576561-9B8363F8-423E-40DD-8E16-F28B50D40D95
P2860
ADAMTS13-binding IgG are present in patients with thrombotic thrombocytopenic purpura.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
ADAMTS13-binding IgG are present in patients with thrombotic thrombocytopenic purpura.
@ast
ADAMTS13-binding IgG are present in patients with thrombotic thrombocytopenic purpura.
@en
type
label
ADAMTS13-binding IgG are present in patients with thrombotic thrombocytopenic purpura.
@ast
ADAMTS13-binding IgG are present in patients with thrombotic thrombocytopenic purpura.
@en
prefLabel
ADAMTS13-binding IgG are present in patients with thrombotic thrombocytopenic purpura.
@ast
ADAMTS13-binding IgG are present in patients with thrombotic thrombocytopenic purpura.
@en
P2093
P2860
P1476
ADAMTS13-binding IgG are present in patients with thrombotic thrombocytopenic purpura.
@en
P2093
Enriqueta Guinto
Han-Mou Tsai
Jacob H Rand
Mojgan Raoufi
Nickolas Grafos
Robert S Greenfield
Safi Ranzurmal
Wenhua Zhou
P2860
P304
P577
2006-05-01T00:00:00Z